Page last updated: 2024-09-04

ezetimibe and Experimental Mammary Neoplasms

ezetimibe has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coticchia, CM; Curatolo, AS; Moses, MA; Pelton, K; Schaffner, CP; Solomon, KR; Zurakowski, D1
Archer, MC; McNamara, E1

Other Studies

2 other study(ies) available for ezetimibe and Experimental Mammary Neoplasms

ArticleYear
Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.
    The American journal of pathology, 2014, Volume: 184, Issue:7

    Topics: Animals; Apoptosis; Azetidines; Cell Line, Tumor; Cell Proliferation; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Ezetimibe; Female; Humans; Hypercholesterolemia; Mammary Neoplasms, Experimental; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic

2014
Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in rats.
    International journal of cancer, 2010, Aug-15, Volume: 127, Issue:4

    Topics: Animals; Anticholesteremic Agents; Azetidines; Carcinogens; Cholesterol, Dietary; Ezetimibe; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley

2010